Cancer Center Business Summit
Home Registration Hosts Advisors Speaker Sponsors Program Information Contact Us

 
 


2017 Cancer Center Business Summit
Transforming the Business of Oncology
through Science and Technology

February 6-7, 2017 ● Las Vegas, NV
The Aria Resort

The 2017 Cancer Center Business Summit Program content is under development at this time. Topics presented at the 2017 Summit will be consistent with the 2017 Summit theme: Transforming the Business of Oncology through Science and Technology. If you have suggestions or comments with regard to topics that you believe are relevant to the 2017 Summit agenda, please forward your ideas to us at: 
dmitka@meetings-incentives.com.
 
Monday, February 6, 2017 Plenary Sessions

1

Opening Keynote: Washington Healthcare Outlook under the new Administration
2 Impact of Reform at the Receiving End: Providers & Patients
Reform by regulatory fiat…added costs, added anxiety, what are we accomplishing? Will reform actually result in a net/overall savings? Financial toxicity, affordability…impact of all this on providers. How is reform impacting patients? Health Plan perspective…are health plans thinking of this differently?
3 Clinical Pathways: With What Result?
How have the use of clinical pathways/guidelines changed clinical practice in oncology? Do pathways create value?
4 Alternative Payment Models in Oncology: Today, Tomorrow and the Transition to Risk
Today: Oncology APMs in place today, risk and non-risk models, including OCM update. Demonstration of actual results. Reconcile with MACRA Tomorrow: accelerate transition to risk models; risk stratification, managing and mitigating risk.
Afternoon Breakout Sessions 2 tracks x 3 sessions
1 MACRA: Implications for Oncologists
Reconcile implications of MIPS and Advanced Alternative Payment Models for Oncology
2 Remaining Independent: Practice Mergers & Acquisitions, Enterprise Scale, Collaborative Networks
3 Integrated Practice-Hospital Affiliations
PSA/Co-Management transactions; achieving best of class” infrastructure; performance standards
4 Building the Regional Cancer Care Collaborative
Hospital/health system oncology service lines and the particular AMC conundrum of meeting community oncology needs without duplicating investments; funding the research and teaching missions under alternative payment and connecting at the level of community care
 
5 Operational & Cultural Change
Resource and talent planning foe operational effectiveness and consistency in a rapidly changing care delivery system
6 Incorporating Genomic Science into Community Oncology
Omics arrives on Main Street; retrospective analysis of 3,000 patients with molecular models – choices made
Tuesday, February 7, 2017 Plenary Sessions
1 Data Technology: Today’s Realities and Tomorrow’s Promise
Data interoperability, connecting patients and caregivers; artificial intelligence; using real world evidence/data to treat patients; how will technology affect patients, providers and decision making? Will technology actually save costs?
2 Supply Chain Disruption and Innovation
Cost of drug; drug availability; comparative effectiveness, specialty pharma, shift to oral chemo; immunotherapy; is cost of drug or cost of providers the culprit in driving cancer care affordability?
3 Oncology Office of the Future: The Look & Feel
The essential elements: people, plant & equipment. Dealing effectively with IT technology; implementation and management in cost control environment; how to organize your practice to incorporate precision medicine, clinical trials, immunotherapy. With what ROI?
Afternoon Breakout Sessions 3 tracks x 2 sessions each
1 Legal & Regulatory Update
340B, site-of-service, MACRA, other current legal topics impacting oncology

2

Oncology Business Transactional Issues
Practice mergers, acquisitions, valuation, operational conversion planning. Hospital alignment transactions acquisitions, valuation, operational conversion planning; site-of-service cost differential under alternative payment models
3 Oncology Care Models (OCM) Best Practices
What are the evolving “best practices” for OCM operations? How is OCM data being complied, interpreted, reported and what are the outstanding unresolved issues?
4 Palliative Care Solutions
Implementation and management; economic implications under alternative payment
5 Enabling Patient Engagement
Patient self-care; patient reported outcomes; patient care monitoring; shared decision making; performance tracking. Disruptive technology/tools
6 The Soft-Side: Business Opportunity in Care Transformation
Using risk dollars to address social determinants of health, psychosocial problems, palliative care counseling, genetics counseling, complementary medicine, and other health factors without a traditional ROI